# Apartment Investment & Management Co: financial statements, quarterly

AIV · NYSE · CIK 922864 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aiv.md) · [Financials](/companies/aiv/financials.md) · [Filings](/companies/aiv/filings.md) · [Insiders](/companies/aiv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aiv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [45.7](/filings/0000950170-24-092826.md) | [47.7](/filings/0000950170-24-123460.md) | [(17.7) d](/filings/0001193125-26-085547.md) | [50.2](/filings/0000950170-25-067034.md) | [51.1](/filings/0001193125-25-177967.md) | [35.3](/filings/0001193125-25-274542.md) | [36.1 d](/filings/0001193125-26-085547.md) | [22.9](/filings/0001193125-26-216904.md) | [52.8](/filings/0001193125-25-177967.md) | [35.1](/filings/0001193125-25-274542.md) | [34.6 d](/filings/0001193125-26-085547.md) | [6.2](/filings/0001193125-26-216904.md) |
| Operating income | $m | [2.0](/filings/0000950170-24-092826.md) | [3.4](/filings/0000950170-24-123460.md) | [106 d](/filings/0000950170-25-025775.md) | [29.0](/filings/0000950170-25-067034.md) | [28.6](/filings/0001193125-25-177967.md) | [17.7](/filings/0001193125-25-274542.md) | [65.7 d](/filings/0000950170-25-025775.md) | [9.7](/filings/0001193125-26-216904.md) | [29.6](/filings/0001193125-25-177967.md) | [18.2](/filings/0001193125-25-274542.md) | not reported | [2.0](/filings/0001193125-26-216904.md) |
| Interest expense | $m | [9.7](/filings/0000950170-24-092826.md) | [8.3](/filings/0000950170-24-123460.md) | [(0.7) d](/filings/0001193125-26-085547.md) | [13.4](/filings/0000950170-25-067034.md) | [16.8](/filings/0001193125-25-177967.md) | [16.3](/filings/0001193125-25-274542.md) | [18.2 d](/filings/0001193125-26-085547.md) | [11.7](/filings/0001193125-26-216904.md) | [18.0](/filings/0001193125-25-177967.md) | [14.0](/filings/0001193125-25-274542.md) | [15.2 d](/filings/0001193125-26-085547.md) | not reported |
| Income tax | $m | [(0.4)](/filings/0000950170-24-092826.md) | [(6.2)](/filings/0000950170-24-123460.md) | [(1.9) d](/filings/0001193125-26-085547.md) | [(2.7)](/filings/0000950170-25-067034.md) | [(2.2)](/filings/0001193125-25-177967.md) | [(3.8)](/filings/0001193125-25-274542.md) | [(2.3) d](/filings/0001193125-26-085547.md) | [(0.1)](/filings/0001193125-26-216904.md) | [5.6](/filings/0001193125-25-177967.md) | [(0.1)](/filings/0001193125-25-274542.md) | [(63.0) d](/filings/0001193125-26-085547.md) | not reported |
| Net income | $m | [(3.6)](/filings/0000950170-24-092826.md) | [(2.3)](/filings/0000950170-24-123460.md) | [(151) d](/filings/0001193125-26-085547.md) | [(10.2)](/filings/0000950170-25-067034.md) | [(60.5)](/filings/0001193125-25-177967.md) | [(21.9)](/filings/0001193125-25-274542.md) | [(11.3) d](/filings/0001193125-26-085547.md) | [(13.9)](/filings/0001193125-26-216904.md) | [(19.3)](/filings/0001193125-25-177967.md) | [283](/filings/0001193125-25-274542.md) | [297 d](/filings/0001193125-26-085547.md) | [(7.7)](/filings/0001193125-26-216904.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0000950170-24-092826.md) | [(0.02)](/filings/0000950170-24-123460.md) | not reported | [(0.07)](/filings/0000950170-25-067034.md) | [(0.43)](/filings/0001193125-25-177967.md) | [(0.16)](/filings/0001193125-25-274542.md) | not reported | [(0.10)](/filings/0001193125-26-216904.md) | [(0.14)](/filings/0001193125-25-177967.md) | [2.04](/filings/0001193125-25-274542.md) | not reported | [(0.05)](/filings/0001193125-26-216904.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0000950170-24-092826.md) | [(0.02)](/filings/0000950170-24-123460.md) | not reported | [(0.07)](/filings/0000950170-25-067034.md) | [(0.43)](/filings/0001193125-25-177967.md) | [(0.16)](/filings/0001193125-25-274542.md) | not reported | [(0.10)](/filings/0001193125-26-216904.md) | [(0.14)](/filings/0001193125-25-177967.md) | [2.04](/filings/0001193125-25-274542.md) | not reported | [(0.05)](/filings/0001193125-26-216904.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-01-31) | period not labelled (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [95.7](/filings/0000950170-23-059416.md) | [123](/filings/0001193125-26-085547.md) | [122](/filings/0000950170-24-055744.md) | [88.5](/filings/0000950170-24-092826.md) | [82.6](/filings/0000950170-24-123460.md) | [141](/filings/0001193125-26-085547.md) | [49.1](/filings/0000950170-25-067034.md) | [41.4](/filings/0001193125-25-177967.md) | [404](/filings/0001193125-25-274542.md) | [395](/filings/0001193125-26-216904.md) | [320](/filings/0001193125-26-216904.md) | [216](/filings/0001193125-26-216904.md) |
| Total assets | $m | [2,251](/filings/0000950170-23-059416.md) | [2,089](/filings/0000950170-25-025775.md) | [2,120](/filings/0000950170-24-055744.md) | [2,057](/filings/0000950170-24-092826.md) | [2,068](/filings/0000950170-24-123460.md) | [1,957](/filings/0001193125-26-085547.md) | [1,873](/filings/0000950170-25-067034.md) | [1,870](/filings/0001193125-25-177967.md) | [2,077](/filings/0001193125-25-274542.md) | [1,676](/filings/0001193125-26-216904.md) | not reported | [1,434](/filings/0001193125-26-216904.md) |
| Total liabilities | $m | [1,495](/filings/0000950170-23-059416.md) | [1,498](/filings/0000950170-25-025775.md) | [1,541](/filings/0000950170-24-055744.md) | [1,564](/filings/0000950170-24-092826.md) | [1,600](/filings/0000950170-24-123460.md) | [1,645](/filings/0001193125-26-085547.md) | [1,570](/filings/0000950170-25-067034.md) | [1,587](/filings/0001193125-25-177967.md) | [1,822](/filings/0001193125-25-274542.md) | [1,123](/filings/0001193125-26-216904.md) | not reported | [728](/filings/0001193125-26-216904.md) |
| Long-term debt | $m | [1,120](/filings/0000950170-23-059416.md) | [1,148](/filings/0000950170-25-025775.md) | [1,182](/filings/0000950170-24-055744.md) | [1,211](/filings/0000950170-24-092826.md) | [1,251](/filings/0000950170-24-123460.md) | [830](/filings/0001193125-26-085547.md) | [1,083](/filings/0000950170-25-067034.md) | [1,098](/filings/0001193125-25-177967.md) | [829](/filings/0001193125-25-274542.md) | [457](/filings/0001193125-26-216904.md) | not reported | not reported |
| Shareholders' equity | $m | [509](/filings/0000950170-23-059416.md) | [350](/filings/0000950170-25-025775.md) | [336](/filings/0000950170-24-055744.md) | [254](/filings/0000950170-24-092826.md) | [230](/filings/0000950170-24-123460.md) | [123](/filings/0001193125-26-085547.md) | [110](/filings/0000950170-25-067034.md) | [91.7](/filings/0001193125-25-177967.md) | [62.0](/filings/0001193125-25-274542.md) | [362](/filings/0001193125-26-216904.md) | [389](/filings/0001193125-26-216904.md) | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.6](/filings/0000950170-24-055744.md) | [12.1 d](/filings/0000950170-24-092826.md) | [24.9 d](/filings/0000950170-24-123460.md) | [7.9 d](/filings/0001193125-26-085547.md) | [21.7](/filings/0000950170-25-067034.md) | [8.0 d](/filings/0001193125-25-177967.md) | [16.4 d](/filings/0001193125-25-274542.md) | [0.8 d](/filings/0001193125-26-085547.md) | [3.8](/filings/0001193125-26-216904.md) | [9.7 d](/filings/0001193125-25-177967.md) | [8.9 d](/filings/0001193125-25-274542.md) | [(14.3) d](/filings/0001193125-26-085547.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [88.2](/filings/0001193125-26-216904.md) | [0.0 d](/filings/0001193125-25-177967.md) | [0.0 d](/filings/0001193125-25-274542.md) | [327 d](/filings/0001193125-26-085547.md) |
| Share repurchases | $m | [14.5](/filings/0000950170-24-055744.md) | [7.9 d](/filings/0000950170-24-092826.md) | [14.4 d](/filings/0000950170-24-123460.md) | [10.1 d](/filings/0001193125-26-085547.md) | [6.6](/filings/0000950170-25-067034.md) | [24.4 d](/filings/0001193125-25-177967.md) | [3.2 d](/filings/0001193125-25-274542.md) | [4.8 d](/filings/0001193125-26-085547.md) | [0.3](/filings/0001193125-26-216904.md) | [0.0 d](/filings/0001193125-25-177967.md) | [0.0 d](/filings/0001193125-25-274542.md) | [0.0 d](/filings/0001193125-26-085547.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [150](/filings/0000950170-23-039094.md) | [151](/filings/0000950170-23-059416.md) | [146](/filings/0000950170-24-055744.md) | [144](/filings/0000950170-24-092826.md) | [143](/filings/0000950170-24-123460.md) | [141](/filings/0000950170-25-067034.md) | [140](/filings/0001193125-25-177967.md) | [137](/filings/0001193125-25-274542.md) | [137](/filings/0001193125-26-216904.md) | [137](/filings/0001193125-25-177967.md) | [139](/filings/0001193125-25-274542.md) | [140](/filings/0001193125-26-216904.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 143,856,183 at 2026-05-08, from the cover of the [10-Q filed 2026-05-11](/filings/0001193125-26-216904.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.